ivonescimab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
ivonescimab
Jun 1, 2024, 10:17 |
Blog
Hidehito Horinouchi: HARMONi-A - Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
May 29, 2024, 09:22 |
Blog
Eric K. Singhi: Isn’t it about time we stopped saying that "patients failed treatment"
Eric K. Singhi reshared his previous post on X and added: ; "But…
May 27, 2024, 13:04 |
Insight
Gilberto Lopes: Few of the positive trials we have data for in lung cancer from ASCO24
Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared a…
May 27, 2024, 04:19 |
Opinion
Gilberto Lopes: My top ASCO24 lung cancer abstracts!
Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared…
All:
4
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube